Clinical Trials List
2023-11-01 - 2026-10-31
Phase I
Not yet recruiting4
ICD-10C47.0
Malignant neoplasm of peripheral nerves of head, face and neck
ICD-10C49.0
Malignant neoplasm of connective and soft tissue of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9171.0
Malignant neoplasm of connective and other soft tissue of head, face and neck
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Jeng-Shiun Du Division of Hematology & Oncology
- Chih-Jen Huang Division of Radiation Therapy
- 曾良鵬 Division of Otolaryngology
- 莊舒婷 Division of Radiation Therapy
- Tsung-Jang Yeh Division of Hematology & Oncology
- 王緒佳 Division of Otolaryngology
- Tzu-Yen Huang Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- RUEY-LONG HONG Division of Hematology & Oncology
- 黃彥霖 Division of Others
- Hsiang-Fong Kao Division of Hematology & Oncology
- 楊明翰 Division of Hematology & Oncology
- 王駿瑋 Division of Hematology & Oncology
- YA-FANG CHEN Division of Radiology
- 陳贈成 Division of Otolaryngology
- 陳婉瑜 Division of Radiation Therapy
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Ling-Wei Wang Division of Radiation Therapy
- Tien-Hua Chen Division of Hematology & Oncology
- 胡育文 Division of Radiation Therapy
- Yuan-Hung Wu Division of Radiation Therapy
- 黃品逸 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yao-Ching Wang Division of Radiation Therapy
- 陳珈妤 Division of Hematology & Oncology
- 林亭君 Division of Radiation Therapy
- 廖志穎 Division of Radiation Therapy
- Ming-Yu Lien Division of Hematology & Oncology
- Ying-Chun Lin Division of Radiation Therapy
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
40 participants
